Table 1.

Study endpoints

Primary	Secondary	Tertiary
Days at home at 30 days	Comprehensive Complications Index	Time to resumption of normal diabetes therapy
	Quality of Recovery Scale (QoR-15)	Incidence of diabetic ketoacidosis or hypoglycaemia
	30-day mortality	incidence and duration of use of intravenous insulin infusion therapy
	Length of stay in hospital	Incidence of diabetic ketoacidosis or hypoglycaemia
	Length of stay in ICU (if applicable)	Change in diabetic management at 30 days
	Incidence of specific major adverse events

ICU, Intensive Care Unit.